Taysha Gene Therapies, Inc.

Siren, L.L.C. TSHA
Report date
6/30/2026
Quarter
2026 Q2
Filed
8/13/2026
Shares
9,846,579
Value ($000)
67,055
Weight
1.4%
2024 Q3 - 2026 Q2 (8 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).